[Ip-health] Indonesia Licenses Patents for Seven HIV & Hepatitis B Medicines -- Precedent-Setting Government Order has Extraordinary Lifesaving Potential
pmaybarduk at citizen.org
Thu Oct 11 05:50:02 PDT 2012
With apologies, our webpage was not quite ready when this post went around. The promised documents and analysis are up and available now: www.citizen.org/actions-indonesia.
From: ip-health-bounces at lists.keionline.org [mailto:ip-health-bounces at lists.keionline.org] On Behalf Of Burcu Kilic
Sent: Thursday, October 11, 2012 8:11 AM
To: ip-health at lists.keionline.org
Subject: [Ip-health] Indonesia Licenses Patents for Seven HIV & Hepatitis B Medicines -- Precedent-Setting Government Order has Extraordinary Lifesaving Potential
Indonesia Licenses Patents for Seven HIV & Hepatitis B Medicines -- Precedent-Setting Government Order has Extraordinary Lifesaving Potential
On September 3, the government of Indonesia took a quiet but exceptionally important step to expand access to medicines and help save and improve lives of people living with HIV/AIDS and hepatitis B.
President Dr. H. Susilo Bambang Yudhoyono signed a decree authorizing government use of patents for seven HIV/AIDS and hepatitis medicines. If implemented to the full, the measure would introduce widespread generic competition and generate potentially massive cost savings in the world's fourth most populous country. The decree licenses patents for a slate of HIV medicines, and may represent the broadest single use of pharmaceutical patent licensing power by a country since the World Trade Organization 1995 Agreement on Trade-Related Aspects of Intellectual Property (WTO's TRIPS).
Indonesia's action sets a powerful example for other countries and a critical precedent for global public health. The Presidential decree is part of an effort to greatly expand access to newer and more appropriate antiviral and antiretroviral treatments in Indonesia.
The licensed medicines include efavirenz, abacavir, didanosin, lopinavir + ritonavir, tenofovir, tenofovir + emtricitabine, and tenofovir + emtricitabine + efavirenz.
More information, including a copy of the decree (in Indonesian and a rough unofficial English translation), analysis, a table of the licensed medicines, and more on Indonesia's response to HIV and hepatitis B, is available here: www.citizen.org/actions-indonesia.
Congratulations to Sindi Putri, Abdullah Denovan and their colleagues at ITPC Indonesia and JOTHI, among other organizations, who are helping advance access in Indonesia.
Read more about the global campaign to improve access to second-line HIV/AIDS treatment here: www.citizen.org/Kaletra-campaign.
Dr. Burcu Kilic,
Legal Counsel, Global Access to Medicines Program Public Citizen | Protecting Health, Safety and Democracy
TEL: +1 202-588-7792
1600 20th St NW, Washington, DC 20009
Ip-health mailing list
Ip-health at lists.keionline.org
More information about the Ip-health